Form 8-K - Current report:
SEC Accession No. 0001213900-25-055833
Filing Date
2025-06-20
Accepted
2025-06-20 08:00:13
Documents
13
Period of Report
2025-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246125-8k_nkgen.htm   iXBRL 8-K 33184
  Complete submission text file 0001213900-25-055833.txt   244370

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nkgn-20250618.xsd EX-101.SCH 3881
3 XBRL DEFINITION FILE nkgn-20250618_def.xml EX-101.DEF 26778
4 XBRL LABEL FILE nkgn-20250618_lab.xml EX-101.LAB 37007
5 XBRL PRESENTATION FILE nkgn-20250618_pre.xml EX-101.PRE 25402
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0246125-8k_nkgen_htm.xml XML 5593
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 251059113
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)